iRhythm Technologies, Inc. (IRTC) vs Relay Therapeutics, Inc. (RLAY)

A side-by-side comparison of iRhythm Technologies, Inc. and Relay Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IRTC vs RLAY

growth of $100 · dividends reinvested · last 6y
IRTC -7.4% (-1.3%/yr)RLAY -44.7% (-9.4%/yr)IRTC compounded faster over this window
050100150200Start $100202120222023202420252026$93$55
IRTC RLAY

IRTC vs RLAY: by the numbers

  • •RLAY is the larger company ($4.03B vs $3.56B market cap).
  • •Both run net losses; IRTC's is the smaller (-1.69% vs -2763.64% net margin).
  • •IRTC grew revenue faster over the past five years (21.93% vs -34.29% CAGR).

Metrics side by side

Valuation

MetricIRTCRLAY
P/S ratio4.31389.16
P/B ratio19.144.53
EV / EBITDA288.97N/A
FCF yield1.10%N/A

Profitability

MetricIRTCRLAY
Gross margin71.45%76.83%
Operating margin-1.17%-1971.59%
Net margin-1.69%-2763.64%
ROE-7.50%-32.14%
ROIC-1.07%-33.87%

Growth (annualized)

MetricIRTCRLAY
Revenue CAGR (5Y)21.93%-34.29%
Total return CAGR (5Y)12.95%-7.92%

Frequently asked

Which has grown faster, IRTC or RLAY?
Over the past five years, IRTC grew revenue faster — IRTC at a 21.93% CAGR versus RLAY at -34.29%.
How have IRTC and RLAY total returns compared?
Over the past 5 years, IRTC delivered 12.95% and RLAY delivered -7.92% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.